kynostatin 272 has been researched along with lopinavir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Hayashi, Y; Hidaka, K; Kameoka, M; Kempf, DJ; Kimura, T; Kiso, Y; Kuroki, R; McDaniel, KF; Nguyen, JT; Sankaranarayanan, R; Wang, J | 1 |
| Akiyama, H; Hayami, M; Ido, E; Ishimatsu, M; Miura, T; Suzuki, H | 1 |
2 other study(ies) available for kynostatin 272 and lopinavir
| Article | Year |
|---|---|
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine.
Topics: Crystallography, X-Ray; Darunavir; Drug Resistance, Viral; Glycine; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Peptidomimetics; Phenylbutyrates; Serum; Structure-Activity Relationship | 2018 |
Construction of a novel SHIV having an HIV-1-derived protease gene and its infection to rhesus macaques: a useful tool for in vivo efficacy tests of protease inhibitors.
Topics: Administration, Oral; Animals; Cell Line; Chimera; Gene Products, gag; HIV Protease; HIV-1; Humans; Leukocytes, Mononuclear; Lopinavir; Macaca fascicularis; Macaca mulatta; Oligopeptides; Protease Inhibitors; Pyrimidinones; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Transfection; Viral Load; Virus Replication | 2007 |